Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Temporal arteritis risk factors
Introduction
Overview
Overview
Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral. Common risk factors in the development of temporal arteritis include age, hypertension, and thrombocytosis. Less common risk factors in the development of temporal arteritis include allele HLA-DRB1*04 genetic polymorphisms, varicella zoster virus infection, and smoking.
Risk Factors
Risk Factors
The risk factors of temporal arteritis are as follows:
Common Risk Factors
- Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral. Common risk factors in the development of temporal arteritis include:[1][2][3]
- Age > 50 years
- Hypertension
- Thrombocytosis
- Female
Less Common Risk Factors
- Less common risk factors in the development of temporal arteritis include:[4]
References
References
- ↑ Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A; et al. (2004). “Risk factors for cranial ischemic complications in giant cell arteritis”. Medicine (Baltimore). 83 (2): 114–22. PMID 15028965.
- ↑ González-Gay MA, GarcÃa-Porrúa C, Llorca J, Hajeer AH, Brañas F, Dababneh A; et al. (2000). “Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients”. Medicine (Baltimore). 79 (5): 283–92. PMID 11039076.
- ↑ Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G; et al. (2005). “Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis”. Arthritis Rheum. 53 (2): 293–7. doi:10.1002/art.21075. PMID 15818722.
- ↑ Mahr, A.; Aouba, A.; Richebé, P.; Gonzalez-Chiappe, S. (2017). “Épidémiologie et histoire naturelle de l’artérite à cellules géantes (Horton)”. La Revue de Médecine Interne. 38 (10): 663–669. doi:10.1016/j.revmed.2017.03.007. ISSN 0248-8663.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]